Health & Bio
InHandPlus Secures USD 2.3 million Series A Investment to Expand AI-Powered Medication Management System
Seoul-based startup InHandPlus has successfully raised 3 billion won (USD 2.3 million) in a Series A funding round, bolstering the...
Read more
Promedius: Revolutionizing Medical Diagnostics with AI-Powered Osteoporosis Solution
Promedius, a Korean startup specializing in AI solutions for medical diagnostics, has made remarkable advancements in the field of healthcare....
Read more
Munice’s Miracle Night App Promises Groundbreaking Solution to Global Sleep Problems
In a world plagued by sleep problems, a groundbreaking solution has emerged. South Korean startup, Munice has launched an innovative...
Read more
CLOP Receives Seed Investment to Revolutionize AI-Based Eye Disease Management and Prevent Blindness
CLOP, a Korean startup founded by Co-CEOs Sangjun Park and Hyunjun Kim, has recently received seed investment from Future Play...
Read more
Korean startup SPASS gets FDA clearance for AI-based sepsis diagnosis solution
Korean AI medical solutions company, SPASS, announced that its AI-based sepsis diagnosis solution, SpassageQ, has received FDA 510(k) clearance. The...
Read more
Sky Labs’ Groundbreaking Cuffless Blood Pressure Monitoring Technology Published in Nature’s Scientific Reports
Sky Labs' paper on cuffless blood pressure measurement technology, titled "Continuous cuffless blood pressure monitoring using photoplethysmography-based PPG2BP-net for high...
Read more
Seoul Metropolitan Govt Partners with ‘Elephant’ App to Enhance Citizen Welfare through Mental Health Services
The Seoul Metropolitan Government is working towards its policy goal of increasing the healthy lifespan of Seoul citizens from 71.9...
Read more
MEDIAIPLUS, a Global Clinical Trial Data Platform participates in “Viva Technology 2023” in Paris, France
MEDIAIPLUS, a global clinical trial information platform, will participate in Viva Technology 2023, a technology fair for ICT-based startups held...
Read more
Genome & Company, Developer of Microbiome Anti-cancer Drugs, Participates in the US Bio Exhibition ‘BIO 2023’
Genome & Company, a global biopharmaceutical company, will participate in the "Bio International Convention" (BIO 2023) from June 5 to...
Read more
Korean startups rally support for non-face-to-face medical service as suspension looms
During the COVID-19 pandemic period, non-face-to-face medical service was temporarily permitted in South Korea based on the Infectious Disease Prevention...
Read more